treatment Archives | Be Korea-savvy
Seoul’s Seongdong District to Offer Subsidies for Hair Loss Treatment

Seoul’s Seongdong District to Offer Subsidies for Hair Loss Treatment

SEOUL, May 19 (Korea Bizwire) — Seoul’s Seondong district office said Wednesday it is introducing the country’s first policy of providing the younger generation with subsidies for hair loss treatment. The district enacted relevant ordinances earlier this month to set up a legal basis for the initiative. The ordinance defines ‘hair loss’ as a disease [...]

Gaming Software Designed for ADHD Patients Increases Blood Flow in Brain

Gaming Software Designed for ADHD Patients Increases Blood Flow in Brain

SEOUL, Feb. 25 (Korea Bizwire) — Video games specially developed to treat attention deficit hyperactivity disorder (ADHD) are capable of increasing the blood flow that is lacking in certain parts of the brain, a study showed Thursday. A research team from Chung-Ang University Hospital created a game co-developed by public agencies and private companies and [...]

Gov’t to Strengthen Medical Treatment and Protection System for Drug Addicts

Gov’t to Strengthen Medical Treatment and Protection System for Drug Addicts

SEOUL, Oct. 15 (Korea Bizwire) — Amid a recent increase in the number of drug-dependent people, the government is taking steps step to strengthen drug addiction treatment and protection systems by extending the range of financial support from hospital treatment to outpatient treatment. The Ministry of Health and Welfare said Thursday that it had issued [...]

Covicept Therapeutics Initiates a Phase 2 Clinical Study with PJS-539, an Oral Small Molecule for the Treatment of Patients with COVID-19 (SARS-CoV-2)

Covicept Therapeutics Initiates a Phase 2 Clinical Study with PJS-539, an Oral Small Molecule for the Treatment of Patients with COVID-19 (SARS-CoV-2)

San Diego, USA, Oct. 6 (Korea Bizwire) – Covicept Therapeutics, an antiviral drug development company, announced today that a double-blind, placebo-controlled Phase 2 trial of PSJ-539 has been initiated and has begun enrolling patients with mild-to-moderate COVID-19. PSJ-539 has the potential to become a best-in-class small molecule for the treatment of COVID-19 patients and also has potential [...]

Celltrion to Supply Antibody Treatment for COVID-19 Without Profit Margin in S. Korea

Celltrion to Supply Antibody Treatment for COVID-19 Without Profit Margin in S. Korea

SEOUL, Feb. 20 (Korea Bizwire) — South Korean biopharmaceutical company Celltrion Inc. will supply its antibody treatment for COVID-19 without a profit margin in South Korea, its chairman has said. Celltrion’s CT-P59 won the South Korean drug safety agency’s conditional approval earlier this month, becoming the first locally made treatment for the virus. The drug [...]

Drug Ministry Approves Clinical Trials of Coronavirus Vaccine, Treatment

Drug Ministry Approves Clinical Trials of Coronavirus Vaccine, Treatment

SEOUL, Nov. 24 (Korea Bizwire) – South Korea’s drug safety agency has approved clinical trials of vaccine and treatment candidates currently under development by two local drug manufacturers, industry officials said Tuesday. The Ministry of Food and Drug Safety on Monday gave the green light to conduct a phase one clinical trial of a vaccine [...]

S. Korea to Mass-produce Antibody Treatment of COVID-19 This Month

S. Korea to Mass-produce Antibody Treatment of COVID-19 This Month

SEOUL, Sept. 8 (Korea Bizwire) – South Korea plans to mass-produce an antibody material later this month that can be used to treat the novel coronavirus, health authorities said Tuesday. The country’s Ministry of Food and Drug Safety is currently reviewing phase 2/3 clinical tests for the antibody-based treatment, and aims to mass-produce so-called production verification [...]

Nafamostat Undergoing Clinical Trials After Curing Coronavirus Patients

Nafamostat Undergoing Clinical Trials After Curing Coronavirus Patients

SEOUL, Aug. 5 (Korea Bizwire) — Nafamostat, a drug used to treat acute pancreatitis and prevent blood clotting for patients receiving blood dialysis, was found to be effective against COVID-19, the disease caused by the novel coronavirus. Professors Rhee Ji-young and Jang Suk-bin from Dankook University Hospital published an article detailing the use of nafamostat [...]